review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.3109/07435808809032986 |
P698 | PubMed publication ID | 3049061 |
P2093 | author name string | Hays MT | |
P2860 | cites work | Thyroxine metabolism in untreated and treated pancreatic steatorrhea | Q34020129 |
Determination of Iodothyronine Absorption and Conversion of L-Thyroxine (T4) to L-Triiodothyronine (T3) using Turnover Rate Techniques | Q34216661 | ||
Altered thyroxine metabolism resulting from the chemical carcinogen 3-methylcholanthrene | Q38540354 | ||
Absorption and excretion of the mono-sodium salt of thyroxine labelled with radioactive iodine | Q39446890 | ||
Effect of Propranolol on Extrathyroidal Metabolism of Thyroxine and 3,3′,5-Triiodothyronine Evaluated by Noncompartmental Kinetics* | Q40467773 | ||
Thyroid hormone-binding proteins in plasma facilitate uniform distribution of thyroxine within tissues: a perfused rat liver study | Q41383282 | ||
Malabsorption of Thyroid Hormones After Jejunoileal Bypass for Obesity | Q41602373 | ||
Absorption of Oral Thyroxine in Man | Q43872578 | ||
Absorption of glucuronide conjugate of triiodothyronine | Q45223292 | ||
Thyroxine metabolism in the dog. | Q47697369 | ||
Penicillin-induced changes in function of the isolated perfused rat liver: alterations in thyroxine metabolism and sulfobromophthalein excretion | Q47713996 | ||
The effect of methylcholanthrene on biliary thyroxine excretion in normal and Gunn rats | Q47999458 | ||
Aspects of the absorption of oral L-thyroxine in normal man | Q51668752 | ||
Effects of a polychlorinated biphenyl mixture (aroclor 1254) and DDT on biliary thyroxine excretion in rats. | Q53739880 | ||
Hepatic Bioavailability of Serum Thyroid Hormones in Nonthyroidal Illness* | Q57677490 | ||
P433 | issue | 2-3 | |
P304 | page(s) | 203-224 | |
P577 | publication date | 1988-01-01 | |
P1433 | published in | Endocrine Research | Q5376305 |
P1476 | title | Thyroid hormone and the gut. | |
P478 | volume | 14 |
Q57828023 | A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism |
Q34975159 | Absorption of levothyroxine when coadministered with various calcium formulations |
Q57170960 | Applications for non-invasive thyroid hormone measurements in mammalian ecology, growth, and maintenance |
Q42783754 | Clinical relevancy of the levothyroxine-continuous enteral nutrition interaction |
Q42825229 | Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine |
Q35526537 | Does microbiota composition affect thyroid homeostasis? |
Q57221562 | Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement |
Q43856268 | Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders |
Q55390019 | Increased Requirement of Replacement Doses of Levothyroxine Caused by Liver Cirrhosis. |
Q74045174 | Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome |
Q38912678 | Liquid and softgel levothyroxine use in clinical practice: state of the art. |
Q46301124 | Low doses of cholestyramine in the treatment of hyperthyroidism |
Q55317644 | Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future. |
Q64922738 | Pharmacokinetics and Comparative Bioavailability of a Levothyroxine Sodium Oral Solution and Soft Capsule. |
Q46648333 | Quantifying amount of adsorption of levothyroxine by percutaneous endoscopic gastrostomy tubes. |
Q38768705 | Review of Heterotopic Thyroid Autotransplantation |
Q21296659 | TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis |
Q38746420 | The relationship between thyroid antibody titer and levothyroxine dose in patients with overt primary hypothyroidism |
Q40684368 | Thyroid hormone metabolism. A comparative evaluation |